azyter 15 mg/ g
laboratoires théa s.a.s - azitromycindihydrat - Øyedråper, oppløsning - 15 mg/ g
lyrica 75 mg
farmagon - pregabalin - kapsel, hard - 75 mg
pulmozyme 1 mg/ ml
roche norge as - dornase alfa - inhalasjonsvæske til nebulisator, oppløsning - 1 mg/ ml
voltarol 11.6 mg/ g
haleon denmark aps - diklofenakdietylamin - gel - 11.6 mg/ g
voltarol forte 23.2 mg/ g
haleon denmark aps - diklofenakdietylamin - gel - 23.2 mg/ g
voltaren 23.2 mg/ g
2care4 - diklofenakdietylamin - gel - 23.2 mg/ g
takipril 20 mg/ ml
b. braun melsungen ag - prilokainhydroklorid - injeksjonsvæske, oppløsning - 20 mg/ ml
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - immune sera og immunglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se avsnitt 4. 4 og 5.
blincyto 38.5 mikrog
orifarm as - blinatumomab - pulver til konsentrat og oppløsning til infusjonsvæske, oppløsning - 38.5 mikrog
voraxaze
serb sas - glucarpidase - metabolic side effects of drugs and substances - alle andre terapeutiske produkter - voraxaze is indicated to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity.